ApprovalTrail

Company · Montreal, Quebec, Canada

Ethypharm Inc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
19
19 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
9

Drug products

Authorized products first.

NameDINStatus
M-EDIAT02320398Marketed
M-EDIAT02320428Marketed
M-EDIAT02320436Marketed
M-EDIAT02320444Marketed
M-ESLON02019949Marketed
M-ESLON02019965Marketed
M-ESLON02019957Marketed
M-ESLON02019930Marketed
M-ESLON02177757Marketed
M-ESLON02177749Marketed
NOYADA02543907Marketed
NOYADA02543915Marketed
ESOMEPRAZOLE02417480Approved
ESOMEPRAZOLE02417499Approved
ZOMORPH02254182Approved
ZOMORPH02254190Approved
ZOMORPH02254204Approved
ZOMORPH02254212Approved
ZOMORPH02254220Approved

Notices of Compliance

Newest first.

  • M-ESLONSeptember 17, 2026 · NOC 38325 · Supplement to a New Drug Submission (SNDS)
  • NOYADADecember 18, 2023 · NOC 32368 · New Drug Submission (NDS)
  • ESOMEPRAZOLEMay 12, 2022 · NOC 28145 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • ESOMEPRAZOLENovember 16, 2021 · NOC 27057 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • M-ESLONFebruary 20, 2019 · NOC 21873 · Supplement to a New Drug Submission (SNDS)
  • ESOMEPRAZOLEMarch 13, 2018 · NOC 20614 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • ESOMEPRAZOLEOctober 3, 2016 · NOC 18544 · Abbreviated New Drug Submission (ANDS)
  • M-ESLONMay 30, 2006 · NOC 7994 · New Drug Submission (NDS)
  • ZOMORPHJuly 5, 2005 · NOC 7215 · New Drug Submission (NDS)

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.